Clinical Research Directory
Browse clinical research sites, groups, and studies.
Clinical Value of ETCOc in the Diagnosis and Treatment of ABO-HDN
Sponsor: Women's Hospital School Of Medicine Zhejiang University
Summary
A prospective observational cohort study was designed. 1. Comparing of the clinical indicators between the hemolytic group and the non-hemolytic group,such as End-tidal carbon monoxide corrected for ambient CO(ETCOc),direct antiglobulin test(DAT), the highest total serum bilirubin level and hemoglobin. To explore the role of ETCOc in the diagnosis of neonatal ABO hemolytic disease. 2. Comparing of the clinical indicators between the neonates with IVIG treatment and the neonates without IVIG treatment in ABO hemolytic disease, such as ETCOc,total serum bilirubin level before IVIG treatment and ETCOc,total serum bilirubin level after IVIG treatment.To explore the clinical value of ETCOc in the treatment of ABO hemolytic disease.
Official title: Clinical Value of ETCOc in the Diagnosis and Treatment of ABO Hemolytic Disease of the Newborn
Key Details
Gender
All
Age Range
Any - 7 Days
Study Type
OBSERVATIONAL
Enrollment
112
Start Date
2023-10-31
Completion Date
2026-12-31
Last Updated
2025-02-05
Healthy Volunteers
No
Conditions
Locations (1)
Women's hospital School of medicine Zhejiang University
Hangzhou, China